Cambridge Isotope Laboratories and Chemtatva Joint Venture in Telangana
Analysis based on 7 articles · First reported Mar 14, 2026 · Last updated Mar 16, 2026
This joint venture will significantly boost India's manufacturing capabilities in isotopically labelled compounds, reducing import dependence and strengthening global supply chains for pharmaceutical research tools and advanced electronic materials. It signals positive growth for the life sciences and speciality chemicals sectors in India===Telangana.
Cambridge Isotope Laboratories and Chemtatva Chiral Solutions have announced a strategic joint venture to establish advanced manufacturing capabilities in India===Telangana, India. The venture plans to invest up to Rs 300 crore over the next three years in Genome Valley Phase 4, creating over 250 direct, high-skilled jobs. This initiative will strengthen India's position in manufacturing isotopically labelled molecules, which are crucial for pharmaceutical research, diagnostics, advanced electronics, OLED materials, and semiconductor applications. India===Telangana was chosen due to its strong life sciences ecosystem, skilled talent, robust infrastructure, and proactive government support. Duddilla Sridhar Babu, India===Telangana's Minister for IT and Industries, welcomed the investment, emphasizing the state's emergence as a global destination for high-value manufacturing.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard